Stay updated on Lumasiran in Primary Hyperoxaluria Type 1: Clinical Trial
Sign up to get notified when there's something new on the Lumasiran in Primary Hyperoxaluria Type 1: Clinical Trial page.

Latest updates to the Lumasiran in Primary Hyperoxaluria Type 1: Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedUpdated study status and revised contacts/locations, reflecting current trial progress.SummaryDifference0.0%

- Check17 days agoChange DetectedA new revision entry, Revision: v3.4.2, was added to the history. The funding/operational-status notice and the earlier Revision: v3.4.1 entry were removed.SummaryDifference0.4%

- Check24 days agoChange DetectedAdded a government funding status notice and updated the site revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check31 days agoChange DetectedThe history page now shows a glossary option, green highlights for additions and red highlights for deletions, and a revised 'Revision' banner to indicate version changes; these changes are cosmetic and do not affect the underlying study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check45 days agoChange DetectedRevision: v3.3.4 has been added to the record history, replacing the previous v3.3.3 entry, a minor metadata update that does not affect study data, status, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check66 days agoChange DetectedThe page now shows Revision: v3.3.3. The HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed.SummaryDifference0.1%

Stay in the know with updates to Lumasiran in Primary Hyperoxaluria Type 1: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lumasiran in Primary Hyperoxaluria Type 1: Clinical Trial page.